Literature DB >> 17039573

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.

Pieter H M van Baal1, Talitha L Feenstra, Rudolf T Hoogenveen, G Ardine de Wit, Werner B F Brouwer.   

Abstract

An important subject of debate in cost-utility analysis of health care programmes is whether to include costs of unrelated medical care in life years gained. The inclusion of such costs is likely to be of consequence in the case of primary prevention. This paper presents different strategies regarding the inclusion not only of the costs, but also of the health effects of unrelated medical care in economic evaluations. Four different cost-utility ratios are presented and related to the criterion of internal consistency. In addition, the possibility to relate the ratios to a well-posed decision problem is analysed. An example computes the different ratios for smoking cessation interventions in different age groups. Including health care costs of unrelated medical care in life years gained increases cost utility ratios, but excluding unrelated medical costs favours smoking cessation interventions targeted at older smokers over those at younger smokers. We conclude that for primary prevention only a cost utility ratio that includes both the costs and effects of unrelated medical care meets the criterion of internal consistency and is related to a meaningful decision problem. Therefore, this type of cost-utility ratio should be preferred even if the data requirements may be substantial. Copyright (c) 2006 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17039573     DOI: 10.1002/hec.1181

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  24 in total

1.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

2.  [Economic aspects of prevention].

Authors:  H H König; S Riedel-Heller
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

Review 3.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.

Authors:  Pieter van Baal; David Meltzer; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

5.  Single balloon versus double balloon bipedicular kyphoplasty: a systematic review and meta-analysis.

Authors:  Zehao Jing; Jianli Dong; Zhengwei Li; Feng Nan
Journal:  Eur Spine J       Date:  2018-06-19       Impact factor: 3.134

6.  Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.

Authors:  Michelle Tew; Philip Clarke; Karin Thursky; Kim Dalziel
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

7.  Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Authors:  David R Rappange; Werner B F Brouwer; Rudolf T Hoogenveen; Pieter H M Van Baal
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 8.  Cost-effectiveness of interventions to promote fruit and vegetable consumption.

Authors:  Linda J Cobiac; Theo Vos; J Lennert Veerman
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Cost-effectiveness of an opportunistic screening programme and brief intervention for excessive alcohol use in primary care.

Authors:  Luqman Tariq; Matthijs van den Berg; Rudolf T Hoogenveen; Pieter H M van Baal
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

10.  Cost-effectiveness of lifestyle modification in diabetic patients.

Authors:  Monique A M Jacobs-van der Bruggen; Pieter H van Baal; Rudolf T Hoogenveen; Talitha L Feenstra; Andrew H Briggs; Kenny Lawson; Edith J M Feskens; Caroline A Baan
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.